Literature DB >> 25870204

The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement?

Francesco Maisano1, Ottavio Alfieri2, Shmuel Banai3, Maurice Buchbinder4, Antonio Colombo2, Volkmar Falk5, Ted Feldman6, Olaf Franzen7, Howard Herrmann8, Saibal Kar9, Karl-Heinz Kuck10, Georg Lutter11, Michael Mack12, Georg Nickenig13, Nicolo Piazza14, Mark Reisman15, Carlos E Ruiz16, Joachim Schofer17, Lars Søndergaard7, Gregg W Stone18, Maurizio Taramasso19, Martyn Thomas20, Alec Vahanian21, John Webb22, Stephan Windecker23, Martin B Leon18.   

Abstract

Transcatheter mitral interventions has been developed to address an unmet clinical need and may be an alternative therapeutic option to surgery with the intent to provide symptomatic and prognostic benefit. Beyond MitraClip therapy, alternative repair technologies are being developed to expand the transcatheter intervention armamentarium. Recently, the feasibility of transcatheter mitral valve implantation in native non-calcified valves has been reported in very high-risk patients. Acknowledging the lack of scientific evidence to date, it is difficult to predict what the ultimate future role of transcatheter mitral valve interventions will be. The purpose of the present report is to review the current state-of-the-art of mitral valve intervention, and to identify the potential future scenarios, which might benefit most from the transcatheter repair and replacement devices under development. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Transcatheter mitral implantation; Transcatheter mitral intervention; Transcatheter mitral repair

Mesh:

Substances:

Year:  2015        PMID: 25870204     DOI: 10.1093/eurheartj/ehv123

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  39 in total

1.  Valvular disease: Functional mitral regurgitation: should all valves be replaced?

Authors:  Maurizio Taramasso; Francesco Maisano
Journal:  Nat Rev Cardiol       Date:  2016-01-04       Impact factor: 32.419

2.  [Therapy of mitral regurgitation is set in motion].

Authors:  K-H Kuck; H Thiele
Journal:  Herz       Date:  2016-02       Impact factor: 1.443

Review 3.  Novel therapeutic strategies for Alzheimer's disease based on the forgotten reproductive hormones.

Authors:  C W Gregory; R L Bowen
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

Review 4.  Estrogens, progestins, menopause and neurodegeneration: basic and clinical studies.

Authors:  J W Simpkins; S-H Yang; Y Wen; M Singh
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

Review 5.  Peri-procedural imaging for transcatheter mitral valve replacement.

Authors:  Navin Natarajan; Parag Patel; Thomas Bartel; Samir Kapadia; Jose Navia; William Stewart; E Murat Tuzcu; Paul Schoenhagen
Journal:  Cardiovasc Diagn Ther       Date:  2016-04

6.  Early experience with transcatheter mitral valve replacement: successes, challenges, and future directions.

Authors:  Chetan P Huded; Milind Y Desai
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

Review 7.  [Interdisciplinary differential treatment of structural heart disease : When operation and when catheter-based intervention?].

Authors:  S Yücel; H Ince; S Kische; M A Sherif; H Bushnaq; A Bärisch; A Öner
Journal:  Herz       Date:  2016-08       Impact factor: 1.443

Review 8.  Mitral regurgitation. Timing of surgery or interventional treatment.

Authors:  A Vahanian; B Iung
Journal:  Herz       Date:  2016-02       Impact factor: 1.443

Review 9.  Established interventions for mitral valve regurgitation. Current evidence.

Authors:  Mathias Orban; D Braun; Martin Orban; L Gross; M Näbauer; C M Hagl; S Massberg; J Hausleiter
Journal:  Herz       Date:  2016-02       Impact factor: 1.443

10.  How Local Annular Force and Collagen Density Govern Mitral Annuloplasty Ring Dehiscence Risk.

Authors:  Eric L Pierce; Andrew W Siefert; Deborah M Paul; Sarah K Wells; Charles H Bloodworth; Satoshi Takebayashi; Chikashi Aoki; Morten O Jensen; Matthew J Gillespie; Robert C Gorman; Joseph H Gorman; Ajit P Yoganathan
Journal:  Ann Thorac Surg       Date:  2016-04-28       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.